Advanced ovarian cancer
Showing 1 - 25 of >10,000
Serous Ovarian Cancer, Advanced Ovarian Cancer Trial (SC0191, Gemcitabine, Paclitaxel)
Not yet recruiting
- Serous Ovarian Cancer
- Advanced Ovarian Cancer
- SC0191
- +2 more
- (no location specified)
Sep 20, 2023
Advanced Ovarian Cancer Trial in Guangzhou (Plasmodium immunotherapy)
Not yet recruiting
- Advanced Ovarian Cancer
- Plasmodium immunotherapy
-
Guangzhou, Guangdong, ChinaThe Third Affiliated Hospital of Southern Medical University
Jul 5, 2023
Ovarian Cancer Trial in Padova (Laparoscopic Debulking Surgery in advanced ovarian cancer, Standard laparotomic Debulking
Recruiting
- Ovarian Cancer
- Laparoscopic Debulking Surgery in advanced ovarian cancer
- Standard laparotomic Debulking Surgery in advanced ovarian cancer
-
Padova, Padova, Veneto, ItalyAzienda Ospedaliera Universitaria di Padova,
May 8, 2023
Ovarian Cancer Trial in Pittsburgh (Olaparib tablet)
Not yet recruiting
- Ovarian Cancer
- Olaparib tablet
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Nov 1, 2023
Ovarian Cancer Stage III, Ovarian Cancer Stage IV Trial (Artificial Intelligence)
Not yet recruiting
- Ovarian Cancer Stage III
- Ovarian Cancer Stage IV
- Artificial Intelligence
- (no location specified)
Aug 24, 2023
ctDNA Predicts Recurrence of Advanced Ovarian Cancer After
Recruiting
- Ovarian Cancer Stage IV
- Ovarian Cancer Stage III
-
Guangzhou, Guangdong, ChinaSun Yat-Sen Memorial Hospital
Aug 30, 2023
Ovarian, Fallopian Tube and Primary Peritoneal Carcinoma Trial in Beijing (Niraparib)
Recruiting
- Ovarian, Fallopian Tube and Primary Peritoneal Carcinoma
-
Beijing, Beijing, ChinaPeking University Cancer Hospital
Nov 15, 2023
Ovarian Cancer Trial in Roma (Blood samples)
Not yet recruiting
- Ovarian Cancer
- Blood samples
-
Roma, ItalyFondazione Policlinico Universitario Agostino Gemelli IRCCS
Oct 3, 2023
Advanced Ovarian Cancer Trial in Seattle (AST-201, Paclitaxel, Carboplatin)
Not yet recruiting
- Advanced Ovarian Cancer
- AST-201
- +4 more
-
Seattle, WashingtonUniversity of Washington
Mar 20, 2023
Ovarian Cancer, Ovarian Tumor, Ovarian Tumor Epithelial Trial (MIRRORS Protocol, Standard Open Cytoreductive Surgery)
Not yet recruiting
- Ovarian Cancer
- +5 more
- MIRRORS Protocol
- Standard Open Cytoreductive Surgery
- (no location specified)
Jul 17, 2023
Olaparib Maintenance Monotherapy in Newly Diagnosed BRCAwt
Not yet recruiting
- Advanced Ovarian Cancer
- None (Observational Study)
- (no location specified)
Mar 8, 2023
Ovarian Cancer, High Grade Serous Adenocarcinoma of Ovary, High Grade Endometrioid Ovarian Cancer Trial in Guangzhou (Fluzoparib
Not yet recruiting
- Ovarian Cancer
- +4 more
- Fluzoparib Capsules
- Bevacizumab
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Cetntre
Sep 25, 2023
Ovarian Carcinoma Trial in Tanta (Itraconazole capsule, Placebo)
Not yet recruiting
- Ovarian Carcinoma
- Itraconazole capsule
- Placebo
-
Tanta, EgyptTanta University, Faculty of Pharmacy
Oct 20, 2022
Ovarian Cancer Trial in Rochester (Exercise - Physical Activity, Resiliency Training, Protein Supplementation)
Recruiting
- Ovarian Cancer
- Exercise - Physical Activity
- +2 more
-
Rochester, MinnesotaMayo Clinic
Jul 15, 2022
Advanced Lung Cancer, Ovarian Cancer Trial in Changsha, Yangzhou, Shanghai (AL2846 capsule)
Recruiting
- Advanced Lung Cancer
- Ovarian Cancer
- AL2846 capsule
-
Changsha, Hunan, China
- +3 more
Apr 4, 2023
Ovarian Cancer, Chemotherapeutic Toxicity Trial in Evanston (Fasting Mimicking Diet (Xentigen by L'Nutra), Carboplatin,
Not yet recruiting
- Ovarian Cancer
- Chemotherapeutic Toxicity
- Fasting Mimicking Diet (Xentigen by L'Nutra)
- +3 more
-
Evanston, IllinoisNorthShore University HealthSystem
Jun 25, 2023
Intraperitoneal Chemotherapy Versus Triweekly Chemotherapy
Recruiting
- Intraperitoneal Chemotherapy, Bevacizumab, Ovarian Cancer
-
Banqiao, New Taipei, TaiwanDepartment of Obstetrics and Gynecology, Far Eastern Memorial Ho
Jan 1, 2023
Ovarian Cancer Trial in Hefei (Pamiparib, Surufatinib)
Recruiting
- Ovarian Cancer
-
Hefei, Anhui, ChinaAnhui Cancer Hospital
Dec 6, 2022
Ovarian Cancer Trial (AK104 - Chemotherapy)
Not yet recruiting
- Ovarian Cancer
- AK104 - Chemotherapy
- (no location specified)
Jun 20, 2022
Ovarian Cancer Trial in Lexington (Artemisia annua 450mg, Artemisia annua 900mg, Artemisia annua 1350mg)
Recruiting
- Ovarian Cancer
- Artemisia annua 450mg
- +4 more
-
Lexington, KentuckyUniversity of Kentucky
Jan 4, 2023
Advanced Fallopian Tube Carcinoma, Advanced Ovarian Carcinoma, Advanced Primary Peritoneal Carcinoma Trial in Portland (Wee1
Not yet recruiting
- Advanced Fallopian Tube Carcinoma
- +10 more
- Wee1 Inhibitor ZN-c3
-
Portland, OregonOHSU Knight Cancer Institute
Jan 25, 2023
Ovarian Cancer, Fatigue, Coping Behavior Trial in Boston, Philadelphia (Enhanced Usual Care (EOC), REVITALIZE ACT Intervention)
Active, not recruiting
- Ovarian Cancer
- +3 more
- Enhanced Usual Care (EOC)
- REVITALIZE ACT Intervention
-
Boston, Massachusetts
- +1 more
Jun 13, 2022
Ovarian Cancer, Cholangiocarcinoma Recurrent, Mesothelioma, Malignant Trial (SynKIR-110, Autologous T cells Transduced with
Not yet recruiting
- Ovarian Cancer
- +2 more
- SynKIR-110, Autologous T cells Transduced with Mesothelin KIR-CAR
- (no location specified)
Oct 5, 2022
Quality of Life After Low Anterior Resection During
Recruiting
- Ovarian Cancer
- +2 more
- Cytoreductive surgery
-
Seoul, Korea, Republic ofSeoul National University Hospital
Jun 19, 2022